eJHaem (Feb 2022)

Acquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination

  • Mawaddah Alislambouli,
  • Andy Veras Victoria,
  • Jyoti Matta,
  • Faye Yin

DOI
https://doi.org/10.1002/jha2.342
Journal volume & issue
Vol. 3, no. 1
pp. 207 – 210

Abstract

Read online

Abstract Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare disease and has occasionally been described after vaccination, especially against viral agents. We present a case of a patient who presents with the classic pentad of TTP a few days after receiving the first dose of the mRNA Pfizer COVID‐19 vaccine. To our knowledge, this is the second report of a de novo TTP following mRNA Pfizer COVID‐19 vaccination.

Keywords